HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (26) Citing Articles via Google Scholar Google Scholar Articles by Woelfle, J. Articles by Rotwein, P. Search for Related Content PubMed PubMed Citation Articles by Woelfle, J. Articles by Rotwein, P.

In vivo regulation of growth hormone-stimulated gene transcription by STAT5b

Molecular Medicine Division, Department of Medicine, Oregon Health and Science University, Portland, Oregon 97239

Submitted 27 August 2003 ; accepted in final form 6 November 2003

The long-term effects of growth hormone (GH) are mediated through coordinated changes in gene expression that are the outcome of interactions between hormone-activated signal transduction pathways and specific feedback loops. Recent studies in mice have implicated the transcription factor STAT5b as part of the GH-regulated somatic growth pathway, because mice lacking this protein showed diminished growth rates. To assess the role of Stat5b in GH-stimulated gene expression, we have delivered modified versions of the protein to the liver of pituitary-deficient male rats by quantitative adenovirus-mediated gene transfer. In pilot studies in cell culture, both constitutive-active and dominant-negative STAT5b showed appropriate binding properties toward a specific DNA response element. After in vivo expression, neither protein prevented nuclear accumulation of STATs 1 and 3 in the liver. Dominant-negative STAT5b completely inhibited GH-stimulated transcription of genes encoding the growth-promoting proteins IGF-I, IGF-binding protein-3 (IGFBP-3), and acid-labile subunit (ALS), which comprise the major circulating IGF-I complex, and blocked expression of the GH inhibitors SOCS-1, SOCS-2, and CIS, but had little effect on induction of SOCS-3. Constitutive-active STAT5b stimulated robust transcription of IGF-I, ALS, and IGFBP-3 in the absence of hormone but did little to modify GH-mediated activation of SOCS family genes. An adenovirus encoding EGFP was without effect. These results, in addition to establishing STAT5b as one of the key agents of GH-stimulated gene transcription, demonstrate the feasibility of using in vivo gene transfer to target and dissect the functions of distinct components of complex hormone-activated signal transduction pathways.

insulin-like growth factor I; suppressors of cytokine signaling; signal transducers and activators of transcription

This article has been cited by other articles:

				S. Lamon, M. A. Wallace, B. Leger, and A. P. Russell Regulation of STARS and its downstream targets suggest a novel pathway involved in human skeletal muscle hypertrophy and atrophy J. Physiol., April 15, 2009; 587(8): 1795 - 1803. [Abstract] [Full Text] [PDF]

				R. Rabkin, I. Awwad, Y. Chen, E. A. Ashley, D. Sun, S. Sood, W. Clusin, P. Heidenreich, G. Piecha, and M.-L. Gross Low-Dose Growth Hormone is Cardioprotective in Uremia J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1774 - 1783. [Abstract] [Full Text] [PDF]

				J. G Miquet, L. Gonzalez, M. N Matos, C. E Hansen, A. Louis, A. Bartke, D. Turyn, and A. I Sotelo Transgenic mice overexpressing GH exhibit hepatic upregulation of GH-signaling mediators involved in cell proliferation J. Endocrinol., August 1, 2008; 198(2): 317 - 330. [Abstract] [Full Text] [PDF]

				M A Fenwick, S Llewellyn, R Fitzpatrick, D A Kenny, J J Murphy, J Patton, and D C Wathes Negative energy balance in dairy cows is associated with specific changes in IGF-binding protein expression in the oviduct Reproduction, January 1, 2008; 135(1): 63 - 75. [Abstract] [Full Text] [PDF]

				Y. Chen, D. Sun, V. M. R. Krishnamurthy, and R. Rabkin Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1856 - E1862. [Abstract] [Full Text] [PDF]

				F. H. Bloomfield, P. L. van Zijl, M. K. Bauer, H. H. Phua, and J. E. Harding Effect of pulsatile growth hormone administration to the growth-restricted fetal sheep on somatotrophic axis gene expression in fetal and placental tissues Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E333 - E339. [Abstract] [Full Text] [PDF]

				D. J. Chia, M. Ono, J. Woelfle, M. Schlesinger-Massart, H. Jiang, and P. Rotwein Characterization of Distinct Stat5b Binding Sites That Mediate Growth Hormone-stimulated IGF-I Gene Transcription J. Biol. Chem., February 10, 2006; 281(6): 3190 - 3197. [Abstract] [Full Text] [PDF]

				J. G. Miquet, A. I. Sotelo, A. Bartke, and D. Turyn Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E600 - E607. [Abstract] [Full Text] [PDF]

				F. Haddad, F. Zaldivar, D. M. Cooper, and G. R. Adams IL-6-induced skeletal muscle atrophy J Appl Physiol, March 1, 2005; 98(3): 911 - 917. [Abstract] [Full Text] [PDF]